BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35503453)

  • 21. BRAF V600E-dependent role of autophagy in uveal melanoma.
    Zhao Y; Wang W; Min I; Wyrwas B; Moore M; Zarnegar R; Fahey TJ
    J Cancer Res Clin Oncol; 2017 Mar; 143(3):447-455. PubMed ID: 27928645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting primary and metastatic uveal melanoma with a G protein inhibitor.
    Onken MD; Makepeace CM; Kaltenbronn KM; Choi J; Hernandez-Aya L; Weilbaecher KN; Piggott KD; Rao PK; Yuede CM; Dixon AJ; Osei-Owusu P; Cooper JA; Blumer KJ
    J Biol Chem; 2021; 296():100403. PubMed ID: 33577798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of p52 and RelB proteins in the metastatic and non-metastatic groups of uveal melanoma with patient outcome.
    Singh MK; Singh L; Chosdol K; Pushker N; Saini N; Meel R; Bakhshi S; Sen S; Kashyap S
    J Cancer Res Clin Oncol; 2019 Dec; 145(12):2969-2982. PubMed ID: 31612319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monosomy 3 Is Linked to Resistance to MEK Inhibitors in Uveal Melanoma.
    Mergener S; Siveke JT; Peña-Llopis S
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Establishment and characterization of a panel of human uveal melanoma xenografts derived from primary and/or metastatic tumors.
    Némati F; Sastre-Garau X; Laurent C; Couturier J; Mariani P; Desjardins L; Piperno-Neumann S; Lantz O; Asselain B; Plancher C; Robert D; Péguillet I; Donnadieu MH; Dahmani A; Bessard MA; Gentien D; Reyes C; Saule S; Barillot E; Roman-Roman S; Decaudin D
    Clin Cancer Res; 2010 Apr; 16(8):2352-62. PubMed ID: 20371695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of tumor-infiltrating CD8
    Johansson J; Siarov J; Kiffin R; Mölne J; Mattsson J; Naredi P; Olofsson Bagge R; Martner A; Lindnér P
    Oncoimmunology; 2020 Dec; 9(1):1854519. PubMed ID: 33344043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopontin expression and serum levels in metastatic uveal melanoma: a pilot study.
    Kadkol SS; Lin AY; Barak V; Kalickman I; Leach L; Valyi-Nagy K; Majumdar D; Setty S; Maniotis AJ; Folberg R; Pe'er J
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):802-6. PubMed ID: 16505010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolutionary Routes in Metastatic Uveal Melanomas Depend on
    Rodrigues M; Mobuchon L; Houy A; Alsafadi S; Baulande S; Mariani O; Marande B; Ait Rais K; Van der Kooij MK; Kapiteijn E; Gassama S; Gardrat S; Barnhill RL; Servois V; Dendale R; Putterman M; Tick S; Piperno-Neumann S; Cassoux N; Pierron G; Waterfall JJ; Roman-Roman S; Mariani P; Stern MH
    Clin Cancer Res; 2019 Sep; 25(18):5513-5524. PubMed ID: 31227496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysregulated GPCR Signaling and Therapeutic Options in Uveal Melanoma.
    Chua V; Lapadula D; Randolph C; Benovic JL; Wedegaertner PB; Aplin AE
    Mol Cancer Res; 2017 May; 15(5):501-506. PubMed ID: 28223438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albumin-based nanostructures for uveal melanoma treatment.
    Latorre A; Latorre A; Castellanos M; Lafuente-Gómez N; Diaz CR; Crespo-Barreda A; Lecea M; Cordani M; Martín-Duque P; Somoza Á
    Nanomedicine; 2021 Jul; 35():102391. PubMed ID: 33794371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma.
    Dai W; Liu S; Wang S; Zhao L; Yang X; Zhou J; Wang Y; Zhang J; Zhang P; Ding K; Li Y; Pan J
    Signal Transduct Target Ther; 2021 May; 6(1):176. PubMed ID: 33976105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives.
    Komatsubara KM; Manson DK; Carvajal RD
    Future Oncol; 2016 Jun; 12(11):1331-44. PubMed ID: 27044592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nestin expression in primary and metastatic uveal melanoma - possible biomarker for high-risk uveal melanoma.
    Djirackor L; Shakir D; Kalirai H; Petrovski G; Coupland SE
    Acta Ophthalmol; 2018 Aug; 96(5):503-509. PubMed ID: 29338117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PD-1 expression on uveal melanoma induces tumor proliferation and predicts poor patient survival.
    Jiang Z; Yan Y; Dong J; Duan L
    Int J Biol Markers; 2020 Sep; 35(3):50-58. PubMed ID: 32686562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
    Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.
    van der Velden PA; Zuidervaart W; Hurks MHMH; Pavey S; Ksander BR; Krijgsman E; Frants RR; Tensen CP; Willemze R; Jager MJ; Gruis NA
    Int J Cancer; 2003 Sep; 106(4):472-479. PubMed ID: 12845640
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis.
    Onken MD; Worley LA; Harbour JW
    Clin Cancer Res; 2008 Jun; 14(12):3737-45. PubMed ID: 18559591
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDAC Inhibition Enhances the
    Faião-Flores F; Emmons MF; Durante MA; Kinose F; Saha B; Fang B; Koomen JM; Chellappan SP; Maria-Engler SS; Rix U; Licht JD; Harbour JW; Smalley KSM
    Clin Cancer Res; 2019 Sep; 25(18):5686-5701. PubMed ID: 31227503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High PTP4A3 phosphatase expression correlates with metastatic risk in uveal melanoma patients.
    Laurent C; Valet F; Planque N; Silveri L; Maacha S; Anezo O; Hupe P; Plancher C; Reyes C; Albaud B; Rapinat A; Gentien D; Couturier J; Sastre-Garau X; Desjardins L; Thiery JP; Roman-Roman S; Asselain B; Barillot E; Piperno-Neumann S; Saule S
    Cancer Res; 2011 Feb; 71(3):666-74. PubMed ID: 21135111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.
    Wu X; Li J; Zhu M; Fletcher JA; Hodi FS
    Mol Cancer Ther; 2012 Sep; 11(9):1905-14. PubMed ID: 22653968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.